e-learning
resources
2022
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
COPD mortality and exacerbations in the placebo group of clinical trials over two decades: a systematic review and meta-regression
Stefan Andreas, Christian Röver, Judith Heinz, Christian Taube, Tim Friede
Source:
ERJ Open Res, 8 (1) 00261-2021; 10.1183/23120541.00261-2021
Journal Issue:
January
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Stefan Andreas, Christian Röver, Judith Heinz, Christian Taube, Tim Friede. COPD mortality and exacerbations in the placebo group of clinical trials over two decades: a systematic review and meta-regression. ERJ Open Res, 8 (1) 00261-2021; 10.1183/23120541.00261-2021
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Systematic review of COPD re-exacerbation and exacerbation treatment failure definitions used in randomised controlled trials (RCTs)
Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS)
Year: 2018
How are recovery and recurrence of COPD exacerbations defined in observational studies? A systematic review
Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS)
Year: 2018
Erdosteine is effective as a treatment for acute exacerbation of COPD: a systematic review of clinical trials
Source: International Congress 2017 – COPD management
Year: 2017
A systematic evaluation of the diagnostic criteria for COPD and exacerbations used in randomised controlled trials on the management of COPD exacerbations
Source: ERJ Open Res, 5 (4) 00136-2019; 10.1183/23120541.00136-2019
Year: 2019
Outcomes reported on the management of COPD exacerbations: a systematic survey of randomised controlled trials
Source: ERJ Open Res, 5 (2) 00072-2019; 10.1183/23120541.00072-2019
Year: 2019
Blood eosinophilia as predictor for outcomes in COPD exacerbations: a systematic review and meta-analysis
Source: International Congress 2017 – Management of COPD
Year: 2017
A systematic review of how patients value COPD outcomes
Source: Eur Respir J, 52 (1) 1800222; 10.1183/13993003.00222-2018
Year: 2018
Efficacy of psychosocial intervention in COPD: a systematic review and meta-analysis
Source: Virtual Congress 2020 – Optimising the benefits of pulmonary rehabilitation
Year: 2020
Risk of mortality associated with formoterol: a systematic review and meta-analysis
Source: Eur Respir J 2009; 34: 803-811
Year: 2009
A systematic review of pharmacotherapeutic clinical trial end-points for bronchiectasis in adults
Source: Eur Respir Rev, 28 (151) 180108; 10.1183/16000617.0108-2018
Year: 2019
Run-in bias in randomised trials: the case of COPD medications
Source: Eur Respir J, 49 (6) 1700361; 10.1183/13993003.00361-2017
Year: 2017
Omalizumab in the real-world: systematic review of asthma control outcomes reported by patients
Source: International Congress 2019 – Clinical studies of asthma treatments
Year: 2019
The long-term clinical and economic impact of COPD exacerbations: an observational study (SHERLOCK)
Source: Virtual Congress 2020 – Prediction and management of outcomes in obstructive diseases
Year: 2020
The utility of tiotropium among patients with chronic obstructive pulmonary disease (COPD): An updated meta-analysis of randomized controlled trials
Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care
Year: 2013
Can antibiotics prevent acute COPD exacerbation? A systematic review and meta-analysis
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013
Bacterial lysate therapy for the prevention of wheezing episodes and asthma exacerbations: a systematic review and meta-analysis
Source: Eur Respir Rev, 29 (158) 190175; 10.1183/16000617.0175-2019
Year: 2020
The burden of exacerbations in mild asthma: a systematic review
Source: ERJ Open Res, 6 (3) 00359-2019; 10.1183/23120541.00359-2019
Year: 2020
The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis
Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection
Year: 2019
Design of pulmonary rehabilitation programmes during acute exacerbations of COPD: a systematic review and network meta-analysis
Source: Eur Respir Rev, 29 (158) 200039; 10.1183/16000617.0039-2020
Year: 2020
Association between COPD exacerbations and acute cardiovascular events: a systematic literature review
Source: Virtual Congress 2021 – Treatments for airway diseases
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept